Company
Kodiak Sciences
Kodiak Sciences has 5 drugs tracked on RxWires: 5 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| KSI-301 | Phase 3 | Macular Edema |
| Tarcocimab | Phase 3 | Diabetic Retinopathy |
| Tarcocimab tedromer | Phase 3 | Wet Age-related Macular Degeneration |
| KSI-101 | Phase 3 | Macular Edema Secondary to Inflammation |
| Tabirafusp tedromer | Phase 3 | Diabetic Macular Edema (DME) |
Latest
- kodiak sciences filed 8-K
- kodiak sciences filed 8-K
- kodiak sciences filed 8-K
- kodiak sciences filed 8-K
- kodiak sciences filed 8-K
Follow Kodiak Sciences on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.